This prospective controlled study recorded the anthropometric data and measured the circulating insulin-like growth factor-I (IGF-I) in 16 children with congenital cyanotic heart disease before and a year after surgical intervention. At presentation patients were significantly shorter [length SD scores (LSDS) ¼ À2.44 AE 1.31], vs. controls (LSDS ¼ À0.25 AE 0.18). After surgical treatment the LSDS and growth velocity SD scores (GVSDS) increased significantly to (À) 0.25 AE 0.95 and 3.7 AE 2.1, respectively. IGF-I increased from 45.7 AE 26.3 ng ml À1 to 67.7 AE 16.4 ng ml
Introduction
Children with congenital heart disease (CHD) have been reported to show significant growth retardation both prenatally and postnatally [1] [2] [3] [4] [5] [6] [7] [8] . Although catch-up growth after successful surgical repair has been reported [8] [9] [10] , medical therapy has been associated with little improvement of their slow growth. Retardation in height as well as weight seems most pronounced in children with cyanotic heart disease, who show more severe weight than height retardation [4] . Advances and recent developments in surgical approach and enteral nutrition have improved the care of these patients [1, [11] [12] [13] . Although catch-up growth usually occurs in children with CHD after surgical intervention, the degree of growth retardation at presentation and the magnitude of catch-up growth and their relation to the change, if any, with important hormones controlling growth [insulin-like growth factor-I (IGF-I), free T4 (FT4) and thyrotropin (TSH)] needs further clarification.
The aim of the present prospective study was to evaluate long-term growth of infants with cyanotic CHD and to look for a possible relationship between echocardiographic parameters at the moment of surgical correction and IGF-I concentration on the one hand and the degree of postsurgical catch-up growth on the other hand.
Patients and methods
Growth parameters for 16 infants with some specific cyanotic CHD were recorded prospectively. These data represent all patients followed up in the department of Pediatric Cardiology, HMC, between 1-2006 and 1-2008. Patients with multiple CHDs, those with associated chromosomal malformations or peculiar syndromes or prematurity were not included in the present study. Our patients were eight females and eight males. They were subdivided in two different groups according to the surgical approach applied. The first group (n ¼ 8) had palliative repair and the second group had full surgical repair of their CHD. Mean operation ages of our patients are given in Table 1 . Mean birthweight and -length were normal for all patient groups and did not differ among the two patient groups.
Ethical approval
Research Ethics Board, Hamad Medical Centre, Doha Qatar approved the protocol of the study and informed consents were obtained from all the parents of the children included in this study.
Methods
All patients were examined thoroughly with special emphasis on: IGF-I, TSH and FT4 were measured by radioimmunometric assay using reagents purchased from Mediagnost, Reutlingen, Germany. Intraassay coefficient of variations (CVs) were 6.6%, 5.9% and 5.8%, respectively, and interassay CVs were 7.9%, 6.9 and 7.2%, respectively. Results are expressed as the mean AE SD and analyzed by paired student t-test to compare growth parameters and analyte concentrations before vs. after surgical treatment. A nonpaired student t-test was used to compare growth parameters and analyte concentrations between patients with CHD and control group. Correlation and linear regression analysis were used to investigate the relation between growth parameters and the other variables. For ethical reasons hormonal and analyte concentrations for normal controls were not measured.
None of the included patients were subsequently excluded. For age periods, three measurements were used in the first year of life. For postoperative periods, three measurements were taken for every patient. Preoperative measurements were taken in the preoperative 2 weeks closest to operation. The relationship between catch-up growth and the severity of preoperative growth failure was evaluated by correlating GVSDS after operation with the growth parameters before surgery. The relationship between catch-up growth and age at time of surgical intervention was also evaluated. Measurement of circulating IGF-I, free thyroxine (FT4) and TSH was done before and 6-12 months after surgery. Hormonal data are correlated with anthropometric and echocardiographic data.
Statistical analysis
Usual parametric statistics were used for calculation of the mean values and confidence intervals. A significant difference was considered to exist between the reference population and our patient data if the mean value of the data set differed from 0 at the 0.05 confidence level. The Pearson Tables 2 and 3 compare the anthropometric data for two groups of patients with cyanotic CHD: Group-1 (n ¼ 8) who had palliative surgery and Group-2 who had complete surgical repair of the defect (n ¼ 8). Group-1 patients were operated on significantly earlier in their life and their LSDS were significantly lower than Group-2 patients before surgery. Group-1 patients had significantly higher GVSDS after surgical intervention. Both groups had significantly increased IGF-I concentrations after vs. before surgery.
The GVSDS after treatment was correlated with the BMI before surgery (r ¼ 0.339, p < 0.05) and negatively with the height SDS (HtSDS) before surgery (r ¼ À0.461, p < 0.05). The percentage increase of IGF-I after operation was correlated significantly with the BMI after surgical intervention (r ¼ 0.82, p < 0.001). GV after surgery was correlated negatively with the age at operation (r ¼ À0.639, p < 0.001). None of the echocardiographic parameters were correlated significantly with the anthropometric parameters. Many factors can contribute to impaired linear growth in these infants including: (i) hypoxia and defective perfusion to the growing tissues including the epiphyseal growth plate, (ii) increased metabolic rate inducing a hyper-metabolic state, (iii) decreased appetite and (iv) possible effect on GH/IGF-I axis [5, 16, 17] .
In our patients with cyanotic CHD, circulating IGF-I concentrations increased significantly after vs. before surgical intervention. After surgery, the percentage change in IGF-I was correlated significantly with GV (r ¼ 0.589, p < 0.01) and BMI (r ¼ 0.82, p < 0.001). These findings supported the view that the attained growth spurt after treatment is mediated through increased IGF-I synthesis (stimulation of GH-IGF-I axis). The GVSDS after treatment was correlated with the BMI before surgery (r ¼ 0.339, p < 0.05) and negatively with the HtSDS before surgery (r ¼ À0.461, p < 0.05). GV after surgery was correlated negatively with the age at operation (r ¼ À0.639, p < 0.001) denoting that early A. EL-SISI ET AL.
TABLE 3
Growth and hormonal data of patients with cyanotic CHD before vs. intervention
TSH TA, tricuspid atresia; TGA, transposition of great artries; D, dextro; PS, pulmonary stenosis; IVS, interventricular septum; DILV, double inlet of left ventricul; TOF, tetralogy of fallot; ASD, atrial septal defect; VSD, ventricular septal defect; 1, before intervention, 2, 1 year after intervention.
surgical interference and higher BMI preoperatively are associated with a better growth spurt. Comparing growth and hormonal data for the two groups of patients with palliative surgery (Group-1) and total correction (Group-2) showed that both groups had significantly accelerated linear growth associated with increased IGF-I after surgery. The GVSDS was significantly higher in the palliative group which may be explained by better growth potential due to their younger age at operation.
In summary, significantly accelerated linear growth after surgical treatment of cyanotic CHD appears to be mediated through activation of the IGF-I synthesis. The correlation between GV after surgery with the BMI before surgery and the significant correlation between percentage increase of IGF-I and the BMI after surgery support the idea that intensive nutritional support to increase BMI before and after surgery appears to be an essential factor determining growth spurt after the operation.
